What’s so special about Ukraine’s minerals? A geologist explains 
As the Black Summer megafires neared, people rallied to save wildlife and domestic animals. But it came at a real cost 
Burkina Faso and Mali’s fabulous flora: new plant life record released 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
Oil Prices Hit Four-Month High as Geopolitical Risks and Supply Disruptions Intensify 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
Starmer’s China Visit Signals New Era in UK–China Economic Relations 
GesiaPlatform Launches Carbon-Neutral Lifestyle App ‘Net Zero Heroes’ 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
Gold and Silver Prices Plunge as Trump Taps Kevin Warsh for Fed Chair 
Wall Street Slips as Tech Stocks Slide on AI Spending Fears and Earnings Concerns 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
UK Housing Market Gains Momentum in Early 2026 as Mortgage Rates Fall 
Indonesia Stocks Face Fragile Sentiment After MSCI Warning and Market Rout 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
SK Geocentric Co. and textile and chemical materials maker Kolon Industries Inc. have commercially released a polybutylene adipate-co-terephthalate (PBAT)-based plastic that they developed jointly.
PBAT is used primarily for various one-off plastic bags and agricultural vinyl, which decomposes more than 90 percent within six months after being buried.
On the other hand, general plastic products take about 100 years to decompose naturally.
Kolon Industries' Gumi plant can produce 3,000 tons of PBAT per year.
SK Geocentric, a chemical affiliate of SK Innovation Co. and South Korea’s only producer of 1,4-butanediol, a main component of PBAT, will supply raw materials to Kolon Industries.
The annual production capacity is expected to be 60,000 tons by 2024.
They signed a strategic partnership in April and since then produced trial products and acquired related certificates before announcing the release of a commercial product.
